CYCCCyclacel Pharmaceuticals, Inc.

Nasdaq cyclacel.com


$ 1.97 $ 0.04 (2.08 %)    

Wednesday, 27-Mar-2024 14:00:29 EDT
QQQ $ 444.97 $ 1.51 (0.34 %)
DIA $ 397.57 $ 4.71 (1.2 %)
SPY $ 523.27 $ 4.36 (0.84 %)
TLT $ 94.66 $ 0.93 (0.99 %)
GLD $ 204.76 $ -0.19 (-0.09 %)
$ 1.96
$ 1.97
$ 0.00 x 0
$ 0.00 x 0
$ 1.97 - $ 1.97
$ 1.82 - $ 13.20
14,688
na
2.58M
$ 1.32
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-21-2024 12-31-2023 10-K
2 11-29-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-08-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-30-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-01-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-13-2020 06-30-2020 10-Q
16 05-12-2020 03-31-2020 10-Q
17 03-05-2020 12-31-2019 10-K
18 11-13-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
20 05-14-2019 03-31-2019 10-Q
21 03-28-2019 12-31-2018 10-K
22 11-13-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-14-2018 03-31-2018 10-Q
25 03-30-2018 12-31-2017 10-K
26 11-13-2017 09-30-2017 10-Q
27 08-10-2017 06-30-2017 10-Q
28 05-12-2017 03-31-2017 10-Q
29 03-31-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
31 08-11-2016 06-30-2016 10-Q
32 05-13-2016 03-31-2016 10-Q
33 03-29-2016 12-31-2015 10-K
34 11-12-2015 09-30-2015 10-Q
35 08-12-2015 06-30-2015 10-Q
36 05-12-2015 03-31-2015 10-Q
37 03-31-2015 12-31-2014 10-K
38 11-12-2014 09-30-2014 10-Q
39 08-12-2014 06-30-2014 10-Q
40 05-13-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cyclacel-pharmaceuticals-q4-eps-623-misses-589-estimate-sales-3100k

Cyclacel Pharmaceuticals (NASDAQ:CYCC) reported quarterly losses of $(6.23) per share which missed the analyst consensus estima...

 earnings-scheduled-for-march-19-2024

Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per...

Core News & Articles

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, NASDAQ:CYCCP, ", Cyclacel", or the ", Company", )))), a biopharmac...

Core News & Articles

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, NASDAQ:CYCCP, ", Cyclacel", or the ", Company", )))), a biopharmac...

 why-juniper-networks-shares-are-trading-higher-by-over-23-here-are-20-stocks-moving-premarket

Shares of Juniper Networks, Inc. (NYSE: JNPR) rose sharply in pre-market trading on Tuesday.

 why-rxsight-shares-are-trading-higher-by-20-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24...

 why-lumiradx-shares-are-trading-lower-by-over-30-here-are-20-stocks-moving-premarket

Shares of LumiraDx Limited (NASDAQ: LMDX) shares fell sharply in pre-market trading. LumiraDx announced its securities will ...

 why-applied-therapeutics-shares-are-trading-lower-by-over-35-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Applied Therapeutics, Inc.

 why-aar-shares-are-trading-lower-by-7-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.

 dow-rises-50-points-feds-preferred-inflation-gauge-cools-in-november

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market o...

 why-cyclacel-pharmaceuticals-cycc-shares-are-getting-obliterated

Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) shares are trading lower by 26.9% to $2.63 Friday morning after the company announc...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION